Skip to main content
. 2017 Jun 28;9:243–248. doi: 10.2147/CMAR.S138643

Table 1.

Characteristics of patients

Characteristics N=60 Exon 21 mutation n, (%)
Exon 19 deletion n, (%)
n=33 n=27
Sex
 Female 44 23 (69.7) 21 (77.8)
 Male 16 10 (30.3) 6 (22.2)
Age
 >60 years 34 22 (66.7) 12 (44.4)
 £60 years 26 11 (33.3) 15 (55.6)
Median age, years (range) 62 (31–84) 63 (39–84) 59 (31–77)
Smoking history
 Never 56 30 (90.9) 26 (96.3)
 Ever 4 3 (9.1) 1 (3.7)
Gefitinib therapy
 First line 41 22 (66.6) 19 (70.3)
 Second line 19 11 (33.3) 8 (29.6)